Cutaneous Adverse Reactions to Valdecoxib Distinct From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
Authors:
- Mirjana ZiemerMZMirjana Ziemer
- Christiane L. WiesendCWChristiane L. Wiesend
- Robert VetterRVRobert Vetter
- Johannes WeissJWJohannes Weiss
- Sabine BlaschkeSBSabine Blaschke
- Johannes NorgauerJNJohannes Norgauer
- Maja MockenhauptMMMaja Mockenhaupt
- 1 June 2007
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 143 (6) , 711-716
Abstract
Research from JAMA Dermatology — Cutaneous Adverse Reactions to Valdecoxib Distinct From Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisKeywords
This publication has 5 references indexed in Scilit:
- Serious dermatologic reaction associated with valdecoxib: Report of two casesJournal of the American Academy of Dermatology, 2004
- Valdecoxib‐Induced Toxic Epidermal Necrolysis in a Patient Allergic to Sulfa DrugsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal NecrolysisArchives of Dermatology, 2002
- Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): Structure and results of a population-based registryJournal of Clinical Epidemiology, 1996
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisNew England Journal of Medicine, 1995